• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CRYOLIFE, INC. HERO GRAFT; VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CRYOLIFE, INC. HERO GRAFT; VASCULAR GRAFT Back to Search Results
Model Number HERO 1002
Device Problems Complete Blockage (1094); Appropriate Term/Code Not Available (3191)
Patient Problems Occlusion (1984); Thrombosis (2100); No Information (3190)
Event Date 07/06/2015
Event Type  Injury  
Event Description
According to the notification form, "dr.(b)(6) placed a left arm hero graft at (b)(6) on (b)(6) 2015.Patient clotted and he and dr.(b)(6) had to do a revision today with a 40 cm procol graft.They exposed the axillary and then cut down and ligated the existing avg at the brachial anastomosis.Used a 4 fogarty and made several passes throughout the entire hero graft to declot the graft.Connected the two grafts end-to-end near the brachial artery.Confirmed patency and closed.".
 
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.
 
Manufacturer Narrative
According to the report, "dr.(b)(6) placed a left arm hero graft at community south on (b)(6) 2015.Patient clotted and he and dr.(b)(6) had to do a revision today with a 40 cm procol graft.They exposed the axillary and then cut down and ligated the existing avg at the brachial anastomosis.Used a 4 fogarty and made several passes throughout the entire hero graft to declot the graft.Connected the two grafts end-to-end near the brachial artery.Confirmed patency and closed." the hospital was unable to provide the lot number of the hero arterial graft component implanted on (b)(6) 2015.Shipping records were queried and lots h14av027 and h15av003 were identified as having been shipped to the hospital in the six months prior to the implant.The manufacturing records for lots h14av027 and h15av003 were reviewed and it was confirmed that all records were controlled, available for review, and met all specifications per the device master record.A review was performed of the available information.The patient was implanted with a hero graft in early (b)(6) 2015.In early (b)(6) 2015, the patient clotted.Partial stenosis or full occlusion of prosthesis or vasculature is listed on the hero instructions for use (ifu) as a potential vascular graft and catheter complication.In this case, the surgeon chose to treat the clot with a graft revision using a 40cm procol graft.The procol graft was attached end-to-end with the arterial graft component near the brachial artery.Before the connection, the surgeon used a "4 fogarty" to declot the entire hero graft.At the end of the procedure patency was confirmed.The ifu lists vascular graft revision/replacement as a potential treatment for vascular graft and catheter complication.Patient medical history was not provided and therefore the risk of clots due to patient characteristics cannot be assessed.An increased risk for graft thrombosis could be caused by a hypercoagulability state or impaired blood flow through the graft.Precautions regarding inadequate anticoagulation are provided in the hero ifu.Operative notes were also unavailable and it cannot be determined if there were any deviations from the suggested implantation methodology.It is also unclear why the surgeon chose to revise the agc with a procol graft.At this time, the role of the hero graft in the aforementioned clotting cannot be determined.The ifu lists the following potential complications with the use of the hero graft: vascular graft revision/replacement and partial stenosis or full occlusion of prosthesis or vasculature.
 
Event Description
According to the notification form, "dr.(b)(6) placed a left arm hero graft on (b)(6) 2015.Patient clotted and he and dr.(b)(6) had to do a revision today with a 40 cm procol graft.They exposed the axillary and then cut down and ligated the existing avg at the brachial anastomosis.Used a 4 fogarty and made several passes throughout the entire hero graft to declot the graft.Connected the two grafts end-to-end near the brachial artery.Confirmed patency and closed.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HERO GRAFT
Type of Device
VASCULAR GRAFT
Manufacturer (Section D)
CRYOLIFE, INC.
1655 roberts blvd., nw
kennesaw GA 30144
Manufacturer (Section G)
CRYOLIFE, INC.
1655 roberts blvd., nw
kennesaw GA 30144
Manufacturer Contact
sandra o'reilly
1655 roberts blvd., nw
kennesaw, GA 30144
7704193355
MDR Report Key4918170
MDR Text Key6010053
Report Number1063481-2015-00110
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K124039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility,Company Representative,company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 07/06/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/16/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberHERO 1002
Device Lot NumberH14AV027 OR H15AV003
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/06/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-